0001415889-22-006386.txt : 20220609 0001415889-22-006386.hdr.sgml : 20220609 20220609165750 ACCESSION NUMBER: 0001415889-22-006386 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220607 FILED AS OF DATE: 20220609 DATE AS OF CHANGE: 20220609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVINE ARNOLD J CENTRAL INDEX KEY: 0001124164 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38520 FILM NUMBER: 221006633 MAIL ADDRESS: STREET 1: C/O JAN STERN REED BAXTER INTERNATIONAL STREET 2: ONE BAXTER PARKWAY DF2 2W CITY: DEERFIELD STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MeiraGTx Holdings plc CENTRAL INDEX KEY: 0001735438 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 EAST 29TH STREET STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 6464902965 MAIL ADDRESS: STREET 1: 450 EAST 29TH STREET STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 4 1 form4-06092022_010640.xml X0306 4 2022-06-07 0001735438 MeiraGTx Holdings plc MGTX 0001124164 LEVINE ARNOLD J 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 true false false false Stock Option (right to buy) 8.25 2022-06-07 4 A 0 15000 0 A 2032-06-07 Ordinary Shares 15000 15000 D Restricted Share Units 2022-06-07 4 A 0 15000 0 A Ordinary Shares 15000 15000 D The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 7, 2023 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2023. Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. The restricted share units shall vest in a single annual installment upon the earlier of (i) June 7, 2023 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2023. /s/ Richard Giroux, Attorney-in-Fact for Arnold J. Levine 2022-06-09